Kapulu M

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.Kibwana E Bundi C Kimani D Nyamako L Keter K Mutiso A Ogwang R Bellamy D Rapi K Bajer A Provstgaard-Morys S Stockdale L Munoz O Datoo MS Lawrie A Ramos-Lopez F Roberts R Hamaluba M Hill AVS Bejon P Ewer KJ Kapulu M
Front Immunol, (2025). 16:1620365

Reversible host cell surface remodelling limits immune recognition and maximizes survival of Plasmodium falciparum gametocytes.Ngotho P Dantzler Press K Peedell M Muasya W Omondi BR Otoboh SE Gomez J Coronado L Seydel KB Kapulu M Laufer M Taylor T Bousema T Marti M
PLoS Pathog, (2025). 21:e1013110

Protein-specific immune response elicited by the Shigella sonnei 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to Shigella.Randall AZ Conti V Nakakana U Liang X Teng AA Di Pasquale AL Kapulu M Frenck R, Jr Launay O Ferruzzi P Scire AS Marchetti E Obiero C Pablo JV Edgar J Bejon P Shandling AD Campo JJ Yee A Martin LB Podda A Micoli F
mSphere, (2025). 10:e0105724

Reversible host cell surface remodelling limits immune recognition and maximizes transmission of Plasmodium falciparum gametocytes.Ngotho P Press KD Peedell M Muasya W Omondi BR Otoboh SE Seydel KB Kapulu M Laufer M Taylor T Bousema T Marti M
bioRxiv, (2024). :

Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023.Kapulu M Manda-Taylor L Balasingam S Means G Ayiro Malungu M Bejon P Chi PC Chiu C Church EC Correa-Oliveira R Day N Durbin A Egesa M Emerson C Jambo K Mathur R Metzger W Mumba N Nazziwa W Olotu A Rodgers J Sinyiza F Talaat K Kamerling I Weller C Baay M Neels P
Biologicals, (2024). 85:101747

Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023.Cavaleri M Kaslow D Boateng E Chen WH Chiu C Choy RKM Correa-Oliveira R Durbin A Egesa M Gibani M Kapulu M Katindi M Olotu A Pongsuwan P Simuyandi M Speder B Talaat KR Weller C Wills B Baay M Balasingam S Olesen OF Neels P
Biologicals, (2024). 85:101745

Controlled Human Malaria Infection Studies in Africa-Past, Present, and Future.Kibwana E Kapulu M Bejon P
Curr Top Microbiol Immunol, (2024). 445:337-365

Safety and immunogenicity of varied doses of R21/Matrix-M vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya.Sang S Datoo MS Otieno E Muiruri C Bellamy D Gathuri E Ngoto O Musembi J Provstgaard-Morys S Stockdale L Aboagye J Woods D Lawrie A Roberts R Keter K Kimani D Ndungu F Kapulu M Njau I Orindi B Ewer KJ Hill AVS Bejon P Hamaluba M
Wellcome Open Res, (2023). 8:450

Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya.Downs LO Campbell C Abouyannis M Otiende M Kapulu M Obiero CW Hamaluba M Ngetsa C Andersson MI Githinji G Warimwe G Baisley K Scott JAG Matthews PC Etyang A
J Virus Erad, (2023). 9:100355

Sporozoite immunization: innovative translational science to support the fight against malaria.Richie TL Church LWP Murshedkar T Billingsley PF James ER Chen MC Abebe Y K CN Chakravarty S Dolberg D Healy SA Diawara H Sissoko MS Sagara I Cook DM Epstein JE Mordmuller B Kapulu M Kreidenweiss A Franke-Fayard B Agnandji ST Lopez Mikue MA McCall MBB Steinhardt L Oneko M Olotu A Vaughan AM Kublin JG Murphy SC Jongo S Tanner M Sirima SB Laurens MB Daubenberger C Silva JC Lyke KE Janse CJ Roestenberg M Sauerwein RW Abdulla S Dicko A Kappe SHI Sim BKL Duffy PE Kremsner PG Hoffman SL
Expert Rev Vaccines, (2023). 22:964-1007

Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study.Chi PC Owino EA Jao I Bejon P Kapulu M Marsh V Kamuya D
BMC Med Ethics, (2022). 23:46

Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop.Williams E Craig K Chiu C Davies H Ellis S Emerson C Jamrozik E Jefford M Kang G Kapulu M Kolstoe SE Littler K Lockett A Elena Rey Messer J McShane H Saenz C Selgelid MJ Shah S Smith PG Yamazaki N
Vaccine, (2022). 40:3484-3489

Equity for excellence in academic institutions: a manifesto for change.Wedekind L Noe A Mokaya J Tamandjou C Kapulu M Ruecker A Kestelyn E Zimba M Khatamzas E Eziefula AC Mackintosh CL Nascimento R Ariana P Best D Gibbs E Dunachie S Hadley G Ravenswood H Young B Kamau C Marsh K McShane H Hale R McPhilbin E Ovseiko PV Oxford Equity in Academia consortium Surender R Worland C White LJ Matthews PC
Wellcome Open Res, (2021). 6:142

Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders.Chi PC Owino EA Jao I Olewe F Ogutu B Bejon P Kapulu M Kamuya D Marsh V Chmi-Sika Study Team
Trials, (2021). 22:494

Engagement of ethics and regulatory authorities on human infection studies: Proceedings of an engagement workshop in Zambia.Kunda-Ng'andu EM Simuyandi M Kapulu M Chirwa-Chobe M Mwanyungwi-Chinganya H Mwale S Chilengi R Sharma A
Wellcome Open Res, (2021). 6:31

Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.Jamrozik E Littler K Bull S Emerson C Kang G Kapulu M Rey E Saenz C Shah S Smith PG Upshur R Weijer C Selgelid MJ WHOWorking Group for Guidance on Human Challenge Studies in COVID
Vaccine, (2021). 39:633-640

Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan-based malaria infection study.Jao I Marsh V Che Chi P Kapulu M Hamaluba M Molyneux S Bejon P Kamuya D
Bioethics, (2020). 34:819-832

Author Correction: The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.Slater HC Ross A Felger I Hofmann NE Robinson L Cook J Goncalves BP Bjorkman A Ouedraogo AL Morris U Msellem M Koepfli C Mueller I Tadesse F Gadisa E Das S Domingo G Kapulu M Midega J Owusu-Agyei S Nabet C Piarroux R Doumbo O Doumbo SN Koram K Lucchi N Udhayakumar V Mosha J Tiono A Chandramohan D Gosling R Mwingira F Sauerwein R Paul R Riley EM White NJ Nosten F Imwong M Bousema T Drakeley C Okell LC
Nat Commun, (2019). 10:2644

Correction to: Detection of Plasmodium falciparum infected Anopheles gambiae using near-infrared spectroscopy.Maia MF Kapulu M Muthui M Wagah MG Ferguson HM Dowell FE Baldini F Ranford-Cartwright L
Malar J, (2019). 18:137

The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.Slater HC Ross A Felger I Hofmann NE Robinson L Cook J Goncalves BP Bjorkman A Ouedraogo AL Morris U Msellem M Koepfli C Mueller I Tadesse F Gadisa E Das S Domingo G Kapulu M Midega J Owusu-Agyei S Nabet C Piarroux R Doumbo O Doumbo SN Koram K Lucchi N Udhayakumar V Mosha J Tiono A Chandramohan D Gosling R Mwingira F Sauerwein R Paul R Riley EM White NJ Nosten F Imwong M Bousema T Drakeley C Okell LC
Nat Commun, (2019). 10:1433